DU
MRNS

Delphia (USA)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Delphia (USA)’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,973
Closed -$86K – 375
2022
Q3 		$86K Buy
+12,973
New +$79.9K 0.1% 258

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

Delphia (USA)'s MRNS Position: Q4 2022 in Review

Delphia (USA) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2022, closing a stake of 12,973 shares — an estimated $86K sold.

Delphia (USA) first reported a position in MRNS in Q3 2022 and held it in 1 quarter. The position peaked at $86K in Q3 2022. 74 funds tracked by Wall St. Rank hold MRNS as of Q4 2022.

  • Delphia (USA) reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2022 after selling out during the quarter.
  • Delphia (USA) sold 12,973 Marinus Pharmaceuticals, Inc shares in Q4 2022, an estimated $86K.
  • Delphia (USA) first reported a position in Marinus Pharmaceuticals, Inc in Q3 2022 and held it in 1 quarter.
  • Delphia (USA)'s Marinus Pharmaceuticals, Inc position peaked at $86K in Q3 2022.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2022.

Based on Delphia (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.